A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum
A Multi-center, Double-blind, Placebo-controlled, Randomized Safety and Efficacy Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum in Pediatric Subjects
Sponsor: ViroXis Corporation
Terminated
Sponsor chose to close
A PHASE2 clinical study on Molluscum Contagiosum, this trial is terminated or withdrawn. The trial is conducted by ViroXis Corporation and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
May 2019 — Jan 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — May 2019 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Terminated PHASE2
-
Nov 2017 — Feb 2018 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Feb 2017 — Nov 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ViroXis Corporation
For direct contact, visit the study record on ClinicalTrials.gov .